Jan Bruha
Overview
Explore the profile of Jan Bruha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fiala O, Pitule P, Hosek P, Liska V, Sorejs O, Bruha J, et al.
Tumour Biol
. 2017 Jul;
39(7):1010428317709283.
PMID: 28714375
MicroRNAs regulate the expression of genes involved in several important cancer-related processes including cell adhesion, proliferation, and tumour angiogenesis. Bevacizumab is routinely used in the treatment of patients with metastatic...
12.
Liska V, Treska V, Skalicky T, Fichtl J, Bruha J, Vycital O, et al.
Anticancer Res
. 2017 Apr;
37(4):2003-2009.
PMID: 28373474
Background/aim: The behavior of tumor markers in biliary tract malignancies is not well-known and has been scarcely studied. Such markers could play important roles in diagnostic and prognostic schemes as...
13.
Treska V, Fichtl J, Bruha J, Liska V, Kormunda S, Finek J
Anticancer Res
. 2017 Mar;
37(3):1529-1533.
PMID: 28314329
Background: Concerns regarding postoperative complications following liver resection for colorectal liver metastases (CLMs) in elderly patients may lead to preference for conservative therapy. The aim of this study was to...
14.
Ludvik J, Duras P, Treska V, Matouskova T, Bruha J, Fichtl J, et al.
Cardiovasc Intervent Radiol
. 2017 Jan;
40(5):690-696.
PMID: 28091729
Objectives: This study aimed to evaluate the progress of future liver remnant volume (FLRV) in patients with liver metastases after portal vein embolization (PVE) with the application of hematopoietic stem...
15.
Treska V, Ferda J, Daum O, Liska V, Skalicky T, Bruha J
Turk J Gastroenterol
. 2016 May;
27(3):252-6.
PMID: 27210781
Background/aims: Liver cystadenomas are rare conditions accounting to approximately 5% of all cystic lesions. The aim of our study was to establish a new diagnostic and complex therapeutic approach. Materials...
16.
Rojas-Rueda D, de Nazelle A, Andersen Z, Braun-Fahrlander C, Bruha J, Bruhova-Foltynova H, et al.
PLoS One
. 2016 Mar;
11(3):e0149990.
PMID: 26930213
Policies that stimulate active transportation (walking and bicycling) have been related to heath benefits. This study aims to assess the potential health risks and benefits of promoting active transportation for...
17.
Bruha J, Vycital O, Tonar Z, Mirka H, Haidingerova L, Benes J, et al.
In Vivo
. 2015 May;
29(3):327-40.
PMID: 25977378
Background: Steatohepatitis is a type of histopathological liver injury that can be caused by chemotherapy [chemotherapy-associated steatohepatitis (CASH)] and can progress to liver fibrosis or cirrhosis. CASH impairs liver functions,...
18.
Treska V, Liska V, Fichtl J, Lysak D, Mirka H, Bruha J, et al.
Anticancer Res
. 2014 Dec;
34(12):7279-85.
PMID: 25503161
Background: Insufficient future liver remnant volume (FLRV) is the main cause of low resectability of liver metastases from colorectal cancer (CLMs). One option for enhancing FLVR growth is the use...
19.
Treska V, cerna M, Liska V, Treskova I, narsanska A, Bruha J
Anticancer Res
. 2014 Mar;
34(3):1281-6.
PMID: 24596373
Background/aim: The results of the surgical treatment of liver metastases from breast cancer (BCLMs) may be determined by various factors. The aim of the present study was to specify the...
20.
Pitule P, Vycital O, Bruha J, Novak P, Hosek P, Treska V, et al.
Anticancer Res
. 2013 Nov;
33(11):4855-65.
PMID: 24222123
Aim: Colorectal cancer (CRC) is one of the most common malignant diseases. The aim of our study was to describe the expression status of 12 selected candidate genes, by comparing...